ArticleOncotarget2017

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.

Ling Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.